Patients with GC having SALL4-positive expression showed worse survival in the Kaplan–Meier survival analysis (3-year overall survival, 0.66 vs. 0.93, log-rank test, P < 0.001, Figure 2A). This evidence concerns the gene SALL4 and gastric cancer.